[
  {
    "startTime": 0.74,
    "endTime": 3.85,
    "text": "[Music]"
  },
  {
    "startTime": 7.27,
    "endTime": 11.66,
    "text": "[Music]"
  },
  {
    "startTime": 17.24,
    "endTime": 19.72,
    "text": "I'd like to share with you the story of"
  },
  {
    "startTime": 19.72,
    "endTime": 23.24,
    "text": "one of my patients called Seline Seline"
  },
  {
    "startTime": 23.24,
    "endTime": 25.8,
    "text": "is a housewife and lives in a rural"
  },
  {
    "startTime": 25.8,
    "endTime": 28.199,
    "text": "District of Cameroon in West Central"
  },
  {
    "startTime": 28.199,
    "endTime": 30.96,
    "text": "Africa 6 years ago at the time of her"
  },
  {
    "startTime": 30.96,
    "endTime": 34.0,
    "text": "HIV diagnosis she was recruited to"
  },
  {
    "startTime": 34.0,
    "endTime": 35.92,
    "text": "participate in a clinical trial which"
  },
  {
    "startTime": 35.92,
    "endTime": 37.559,
    "text": "was running in her health district at"
  },
  {
    "startTime": 37.559,
    "endTime": 38.239,
    "text": "the"
  },
  {
    "startTime": 38.239,
    "endTime": 41.0,
    "text": "time when I first met Seline a little"
  },
  {
    "startTime": 41.0,
    "endTime": 43.76,
    "text": "over a year ago she had gone for 18"
  },
  {
    "startTime": 43.76,
    "endTime": 45.8,
    "text": "months without any anti-retroviral"
  },
  {
    "startTime": 45.8,
    "endTime": 49.879,
    "text": "therapy and she was very ill she told me"
  },
  {
    "startTime": 49.879,
    "endTime": 51.719,
    "text": "that she stopped coming to the clinic"
  },
  {
    "startTime": 51.719,
    "endTime": 54.079,
    "text": "when the trial ended because she had no"
  },
  {
    "startTime": 54.079,
    "endTime": 56.6,
    "text": "money for the bus fair and was too ill"
  },
  {
    "startTime": 56.6,
    "endTime": 60.12,
    "text": "to walk the 35 km distance now now"
  },
  {
    "startTime": 60.12,
    "endTime": 61.879,
    "text": "during the clinical trial she had been"
  },
  {
    "startTime": 61.879,
    "endTime": 64.64,
    "text": "given all her anti-retroviral drugs free"
  },
  {
    "startTime": 64.64,
    "endTime": 67.6,
    "text": "of charge and her Transportation cost"
  },
  {
    "startTime": 67.6,
    "endTime": 70.36,
    "text": "had been covered by the research funds"
  },
  {
    "startTime": 70.36,
    "endTime": 72.56,
    "text": "all of these ended once the trial was"
  },
  {
    "startTime": 72.56,
    "endTime": 75.799,
    "text": "completed leaving Seline with no"
  },
  {
    "startTime": 75.799,
    "endTime": 78.28,
    "text": "Alternatives she was unable to tell me"
  },
  {
    "startTime": 78.28,
    "endTime": 80.04,
    "text": "the names of the drugs she had received"
  },
  {
    "startTime": 80.04,
    "endTime": 82.4,
    "text": "during the trial or even what the trial"
  },
  {
    "startTime": 82.4,
    "endTime": 85.36,
    "text": "had been about I didn't bother to ask"
  },
  {
    "startTime": 85.36,
    "endTime": 88.04,
    "text": "her what the results of the trial were"
  },
  {
    "startTime": 88.04,
    "endTime": 89.92,
    "text": "because it seemed obvious to me that"
  },
  {
    "startTime": 89.92,
    "endTime": 92.799,
    "text": "that she would have no clue yet what"
  },
  {
    "startTime": 92.799,
    "endTime": 95.92,
    "text": "puzzled me most was Seline had given her"
  },
  {
    "startTime": 95.92,
    "endTime": 98.6,
    "text": "informed consent to be a part of this"
  },
  {
    "startTime": 98.6,
    "endTime": 101.52,
    "text": "trial yet she clearly did not understand"
  },
  {
    "startTime": 101.52,
    "endTime": 104.0,
    "text": "the implications of being a participant"
  },
  {
    "startTime": 104.0,
    "endTime": 106.159,
    "text": "or what would happen to her once the"
  },
  {
    "startTime": 106.159,
    "endTime": 108.88,
    "text": "trial had been completed now I have"
  },
  {
    "startTime": 108.88,
    "endTime": 111.719,
    "text": "shared this story with you as an example"
  },
  {
    "startTime": 111.719,
    "endTime": 113.439,
    "text": "of what can happen to participants in"
  },
  {
    "startTime": 113.439,
    "endTime": 116.2,
    "text": "the clinical trial when it is poorly"
  },
  {
    "startTime": 116.2,
    "endTime": 118.68,
    "text": "conducted maybe this particular trial"
  },
  {
    "startTime": 118.68,
    "endTime": 121.159,
    "text": "yielded exciting result results maybe it"
  },
  {
    "startTime": 121.159,
    "endTime": 123.039,
    "text": "even got published in a high-profile"
  },
  {
    "startTime": 123.039,
    "endTime": 125.759,
    "text": "scientific journal maybe it would inform"
  },
  {
    "startTime": 125.759,
    "endTime": 128.119,
    "text": "clinicians around the world on how to"
  },
  {
    "startTime": 128.119,
    "endTime": 130.16,
    "text": "improve on the HIV on the on the"
  },
  {
    "startTime": 130.16,
    "endTime": 133.16,
    "text": "clinical management of HIV patients but"
  },
  {
    "startTime": 133.16,
    "endTime": 135.879,
    "text": "it would have done so at a price to"
  },
  {
    "startTime": 135.879,
    "endTime": 138.76,
    "text": "hundreds of patients who like Seline"
  },
  {
    "startTime": 138.76,
    "endTime": 141.36,
    "text": "were left to their own devices once the"
  },
  {
    "startTime": 141.36,
    "endTime": 144.4,
    "text": "research had been completed I do not"
  },
  {
    "startTime": 144.4,
    "endTime": 147.36,
    "text": "stand here today to suggest in any way"
  },
  {
    "startTime": 147.36,
    "endTime": 149.48,
    "text": "that conducting HIV clinical trials in"
  },
  {
    "startTime": 149.48,
    "endTime": 152.879,
    "text": "develop countries is bad on the contrary"
  },
  {
    "startTime": 152.879,
    "endTime": 155.04,
    "text": "clinical trials are extremely useful"
  },
  {
    "startTime": 155.04,
    "endTime": 157.64,
    "text": "tools and are much needed to address the"
  },
  {
    "startTime": 157.64,
    "endTime": 159.879,
    "text": "burden of disease in developing"
  },
  {
    "startTime": 159.879,
    "endTime": 162.68,
    "text": "countries however the inequalities that"
  },
  {
    "startTime": 162.68,
    "endTime": 165.08,
    "text": "exist between richer countries and"
  },
  {
    "startTime": 165.08,
    "endTime": 167.599,
    "text": "developing countries in terms of funding"
  },
  {
    "startTime": 167.599,
    "endTime": 170.519,
    "text": "pose a real risk for exploitation"
  },
  {
    "startTime": 170.519,
    "endTime": 172.519,
    "text": "especially in a context of externally"
  },
  {
    "startTime": 172.519,
    "endTime": 173.64,
    "text": "funded"
  },
  {
    "startTime": 173.64,
    "endTime": 176.599,
    "text": "research sadly enough the fact remains"
  },
  {
    "startTime": 176.599,
    "endTime": 178.56,
    "text": "that a lot of the studies that are"
  },
  {
    "startTime": 178.56,
    "endTime": 180.879,
    "text": "conducted in devel developing countries"
  },
  {
    "startTime": 180.879,
    "endTime": 183.159,
    "text": "could never be authorized in the Richer"
  },
  {
    "startTime": 183.159,
    "endTime": 185.799,
    "text": "countries which fund the research I'm"
  },
  {
    "startTime": 185.799,
    "endTime": 188.319,
    "text": "sure you must be asking yourselves what"
  },
  {
    "startTime": 188.319,
    "endTime": 190.319,
    "text": "makes developing countries especially"
  },
  {
    "startTime": 190.319,
    "endTime": 193.4,
    "text": "those in subsaharan Africa so attractive"
  },
  {
    "startTime": 193.4,
    "endTime": 196.72,
    "text": "for these HIV clinical trials well in"
  },
  {
    "startTime": 196.72,
    "endTime": 199.72,
    "text": "order for a clinical trial to generate"
  },
  {
    "startTime": 199.72,
    "endTime": 202.599,
    "text": "valid and widely applicable results they"
  },
  {
    "startTime": 202.599,
    "endTime": 204.799,
    "text": "need to be conducted with large numbers"
  },
  {
    "startTime": 204.799,
    "endTime": 208.159,
    "text": "of study participants and preferably on"
  },
  {
    "startTime": 208.159,
    "endTime": 210.319,
    "text": "a population with a high in"
  },
  {
    "startTime": 210.319,
    "endTime": 212.0,
    "text": "of new HIV"
  },
  {
    "startTime": 212.0,
    "endTime": 214.64,
    "text": "infections subsaharan Africa largely"
  },
  {
    "startTime": 214.64,
    "endTime": 217.519,
    "text": "fits this description with 22 million"
  },
  {
    "startTime": 217.519,
    "endTime": 221.68,
    "text": "people living with HIV an estimated 70%"
  },
  {
    "startTime": 221.68,
    "endTime": 223.439,
    "text": "of the 30 million people who are"
  },
  {
    "startTime": 223.439,
    "endTime": 224.599,
    "text": "infected"
  },
  {
    "startTime": 224.599,
    "endTime": 227.159,
    "text": "worldwide also research within the"
  },
  {
    "startTime": 227.159,
    "endTime": 230.2,
    "text": "continent is a lot easier to conduct due"
  },
  {
    "startTime": 230.2,
    "endTime": 233.599,
    "text": "to widespread poverty endemic diseases"
  },
  {
    "startTime": 233.599,
    "endTime": 236.239,
    "text": "and inadequate Health Care Systems a"
  },
  {
    "startTime": 236.239,
    "endTime": 238.799,
    "text": "clinical trial that is considered to be"
  },
  {
    "startTime": 238.799,
    "endTime": 240.599,
    "text": "potentially benef official to the"
  },
  {
    "startTime": 240.599,
    "endTime": 242.959,
    "text": "population is more likely to be"
  },
  {
    "startTime": 242.959,
    "endTime": 245.239,
    "text": "authorized and in the absence of Good"
  },
  {
    "startTime": 245.239,
    "endTime": 248.36,
    "text": "Health Care Systems almost any offer of"
  },
  {
    "startTime": 248.36,
    "endTime": 250.959,
    "text": "medical assistance is accepted as better"
  },
  {
    "startTime": 250.959,
    "endTime": 253.92,
    "text": "than nothing even more problematic"
  },
  {
    "startTime": 253.92,
    "endTime": 257.4,
    "text": "reasons include lower risk of litigation"
  },
  {
    "startTime": 257.4,
    "endTime": 260.32,
    "text": "less rigorous ethical reviews and"
  },
  {
    "startTime": 260.32,
    "endTime": 261.84,
    "text": "populations that are willing to"
  },
  {
    "startTime": 261.84,
    "endTime": 264.8,
    "text": "participate in almost any study that"
  },
  {
    "startTime": 264.8,
    "endTime": 266.6,
    "text": "hints at a"
  },
  {
    "startTime": 266.6,
    "endTime": 270.759,
    "text": "cure as funding for HIV research"
  },
  {
    "startTime": 270.759,
    "endTime": 273.16,
    "text": "increases in developing countries and"
  },
  {
    "startTime": 273.16,
    "endTime": 275.199,
    "text": "ethical review in richer countries"
  },
  {
    "startTime": 275.199,
    "endTime": 277.919,
    "text": "become more strict you can see why this"
  },
  {
    "startTime": 277.919,
    "endTime": 281.639,
    "text": "context becomes very very attractive the"
  },
  {
    "startTime": 281.639,
    "endTime": 284.759,
    "text": "high prevalence of HIV drives"
  },
  {
    "startTime": 284.759,
    "endTime": 287.759,
    "text": "researchers to conduct research that is"
  },
  {
    "startTime": 287.759,
    "endTime": 289.759,
    "text": "sometimes scientifically acceptable but"
  },
  {
    "startTime": 289.759,
    "endTime": 292.16,
    "text": "on many levels ethically"
  },
  {
    "startTime": 292.16,
    "endTime": 294.72,
    "text": "questionable how then can we ensure that"
  },
  {
    "startTime": 294.72,
    "endTime": 297.039,
    "text": "in our search for the Cure we do not"
  },
  {
    "startTime": 297.039,
    "endTime": 299.52,
    "text": "take an unfair advantage of those who"
  },
  {
    "startTime": 299.52,
    "endTime": 301.52,
    "text": "are already most affected by the"
  },
  {
    "startTime": 301.52,
    "endTime": 304.28,
    "text": "pandemic I invite you to consider four"
  },
  {
    "startTime": 304.28,
    "endTime": 306.88,
    "text": "areas I think we can focus on in order"
  },
  {
    "startTime": 306.88,
    "endTime": 308.96,
    "text": "to improve the way in which things are"
  },
  {
    "startTime": 308.96,
    "endTime": 311.68,
    "text": "done the first of these is informed"
  },
  {
    "startTime": 311.68,
    "endTime": 314.12,
    "text": "consent now in order for a clinical"
  },
  {
    "startTime": 314.12,
    "endTime": 316.96,
    "text": "trial to be ethically considered"
  },
  {
    "startTime": 316.96,
    "endTime": 319.44,
    "text": "ethically acceptable participants must"
  },
  {
    "startTime": 319.44,
    "endTime": 321.88,
    "text": "be given the relevant information in a"
  },
  {
    "startTime": 321.88,
    "endTime": 324.039,
    "text": "way in which they can understand and"
  },
  {
    "startTime": 324.039,
    "endTime": 326.88,
    "text": "must freely consent to participate in"
  },
  {
    "startTime": 326.88,
    "endTime": 329.72,
    "text": "the trial this is especially important"
  },
  {
    "startTime": 329.72,
    "endTime": 331.919,
    "text": "in developing countries where a lot of"
  },
  {
    "startTime": 331.919,
    "endTime": 334.479,
    "text": "participants consent to research because"
  },
  {
    "startTime": 334.479,
    "endTime": 336.36,
    "text": "they believe it is the only way in which"
  },
  {
    "startTime": 336.36,
    "endTime": 339.0,
    "text": "they can receive medical care or other"
  },
  {
    "startTime": 339.0,
    "endTime": 341.4,
    "text": "benefits consent procedures that are"
  },
  {
    "startTime": 341.4,
    "endTime": 343.8,
    "text": "used in richer countries are often"
  },
  {
    "startTime": 343.8,
    "endTime": 346.44,
    "text": "inappropriate or ineffective in a lot of"
  },
  {
    "startTime": 346.44,
    "endTime": 349.4,
    "text": "developing countries for example it is"
  },
  {
    "startTime": 349.4,
    "endTime": 351.96,
    "text": "counterintuitive to have an illiterate"
  },
  {
    "startTime": 351.96,
    "endTime": 354.52,
    "text": "study participant like Seline sign a"
  },
  {
    "startTime": 354.52,
    "endTime": 356.12,
    "text": "lengthy consent form that they are"
  },
  {
    "startTime": 356.12,
    "endTime": 359.639,
    "text": "unable to read let alone understand l"
  },
  {
    "startTime": 359.639,
    "endTime": 361.56,
    "text": "local communities need to be more"
  },
  {
    "startTime": 361.56,
    "endTime": 364.08,
    "text": "involved in establishing the criteria"
  },
  {
    "startTime": 364.08,
    "endTime": 366.44,
    "text": "for recruiting participants in clinical"
  },
  {
    "startTime": 366.44,
    "endTime": 369.599,
    "text": "trials as well as the incentives for"
  },
  {
    "startTime": 369.599,
    "endTime": 371.72,
    "text": "participation the information in these"
  },
  {
    "startTime": 371.72,
    "endTime": 373.84,
    "text": "trials needs to be given to the"
  },
  {
    "startTime": 373.84,
    "endTime": 376.319,
    "text": "potential participants in linguistically"
  },
  {
    "startTime": 376.319,
    "endTime": 379.8,
    "text": "and culturally acceptable formats the"
  },
  {
    "startTime": 379.8,
    "endTime": 381.72,
    "text": "second point i' would like for you to"
  },
  {
    "startTime": 381.72,
    "endTime": 384.36,
    "text": "consider is the standard of care that is"
  },
  {
    "startTime": 384.36,
    "endTime": 386.52,
    "text": "provided to participants within any"
  },
  {
    "startTime": 386.52,
    "endTime": 389.199,
    "text": "clinical trial now this is subject to a"
  },
  {
    "startTime": 389.199,
    "endTime": 392.479,
    "text": "lot of debate and controversy should the"
  },
  {
    "startTime": 392.479,
    "endTime": 394.639,
    "text": "control group in a clinical trial be"
  },
  {
    "startTime": 394.639,
    "endTime": 396.759,
    "text": "given the best current treatment which"
  },
  {
    "startTime": 396.759,
    "endTime": 399.68,
    "text": "is available anywhere in the world or"
  },
  {
    "startTime": 399.68,
    "endTime": 401.639,
    "text": "should they be given an alternative"
  },
  {
    "startTime": 401.639,
    "endTime": 403.84,
    "text": "standard of care such as the best"
  },
  {
    "startTime": 403.84,
    "endTime": 406.0,
    "text": "current Treatment available in the"
  },
  {
    "startTime": 406.0,
    "endTime": 408.479,
    "text": "country in which the research is being"
  },
  {
    "startTime": 408.479,
    "endTime": 411.16,
    "text": "conducted is it fair to evaluate a"
  },
  {
    "startTime": 411.16,
    "endTime": 413.36,
    "text": "treatment regimen which may not be"
  },
  {
    "startTime": 413.36,
    "endTime": 416.199,
    "text": "affordable or accessible to the study"
  },
  {
    "startTime": 416.199,
    "endTime": 418.12,
    "text": "participants once the research has been"
  },
  {
    "startTime": 418.12,
    "endTime": 419.639,
    "text": "completed"
  },
  {
    "startTime": 419.639,
    "endTime": 422.319,
    "text": "now in a situation where the best"
  },
  {
    "startTime": 422.319,
    "endTime": 424.4,
    "text": "current treatment is inexpensive and"
  },
  {
    "startTime": 424.4,
    "endTime": 427.199,
    "text": "simple to deliver the answer is"
  },
  {
    "startTime": 427.199,
    "endTime": 429.96,
    "text": "straightforward however the best current"
  },
  {
    "startTime": 429.96,
    "endTime": 431.8,
    "text": "Treatment available anywhere in the"
  },
  {
    "startTime": 431.8,
    "endTime": 434.52,
    "text": "world is often very difficult to provide"
  },
  {
    "startTime": 434.52,
    "endTime": 437.479,
    "text": "in developing countries it is important"
  },
  {
    "startTime": 437.479,
    "endTime": 439.4,
    "text": "to assess the potential risk and"
  },
  {
    "startTime": 439.4,
    "endTime": 441.68,
    "text": "benefits of the standard of care which"
  },
  {
    "startTime": 441.68,
    "endTime": 444.12,
    "text": "is to be provided to participants in any"
  },
  {
    "startTime": 444.12,
    "endTime": 447.319,
    "text": "clinical trial and establish one which"
  },
  {
    "startTime": 447.319,
    "endTime": 449.599,
    "text": "is relevant for the study the for the"
  },
  {
    "startTime": 449.599,
    "endTime": 451.84,
    "text": "context of the study and most beneficial"
  },
  {
    "startTime": 451.84,
    "endTime": 454.44,
    "text": "for the participants within the study"
  },
  {
    "startTime": 454.44,
    "endTime": 456.28,
    "text": "that brings us to the third point I want"
  },
  {
    "startTime": 456.28,
    "endTime": 459.479,
    "text": "you to think about the ethical review of"
  },
  {
    "startTime": 459.479,
    "endTime": 462.24,
    "text": "research an effective system for"
  },
  {
    "startTime": 462.24,
    "endTime": 464.599,
    "text": "reviewing the ethical suitability of"
  },
  {
    "startTime": 464.599,
    "endTime": 467.12,
    "text": "clinical trials is primordial to"
  },
  {
    "startTime": 467.12,
    "endTime": 468.84,
    "text": "safeguard participants within any"
  },
  {
    "startTime": 468.84,
    "endTime": 471.72,
    "text": "clinical trial unfortunately this is"
  },
  {
    "startTime": 471.72,
    "endTime": 475.12,
    "text": "often lacking or inefficient in a lot of"
  },
  {
    "startTime": 475.12,
    "endTime": 478.56,
    "text": "developing countries local governments"
  },
  {
    "startTime": 478.56,
    "endTime": 481.36,
    "text": "need to to set up effective systems for"
  },
  {
    "startTime": 481.36,
    "endTime": 483.4,
    "text": "reviewing the ethical issues around the"
  },
  {
    "startTime": 483.4,
    "endTime": 486.159,
    "text": "clinical trials which are authorized in"
  },
  {
    "startTime": 486.159,
    "endTime": 488.4,
    "text": "different developing countries and they"
  },
  {
    "startTime": 488.4,
    "endTime": 490.84,
    "text": "need to do this by setting up ethical"
  },
  {
    "startTime": 490.84,
    "endTime": 492.759,
    "text": "review committees that are independent"
  },
  {
    "startTime": 492.759,
    "endTime": 496.12,
    "text": "of the government and research sponsors"
  },
  {
    "startTime": 496.12,
    "endTime": 497.919,
    "text": "public accountability needs to be"
  },
  {
    "startTime": 497.919,
    "endTime": 500.44,
    "text": "promoted through transparency and"
  },
  {
    "startTime": 500.44,
    "endTime": 502.919,
    "text": "independent review by non-governmental"
  },
  {
    "startTime": 502.919,
    "endTime": 505.8,
    "text": "and international organizations as"
  },
  {
    "startTime": 505.8,
    "endTime": 508.319,
    "text": "appropriate the final point I'd like for"
  },
  {
    "startTime": 508.319,
    "endTime": 510.159,
    "text": "you to consider tonight"
  },
  {
    "startTime": 510.159,
    "endTime": 512.2,
    "text": "is what happens to participants in the"
  },
  {
    "startTime": 512.2,
    "endTime": 514.479,
    "text": "clinical trial once the research has"
  },
  {
    "startTime": 514.479,
    "endTime": 515.36,
    "text": "been"
  },
  {
    "startTime": 515.36,
    "endTime": 518.32,
    "text": "completed I think it is absolutely wrong"
  },
  {
    "startTime": 518.32,
    "endTime": 520.36,
    "text": "for research to begin in the first place"
  },
  {
    "startTime": 520.36,
    "endTime": 522.76,
    "text": "without a clear plan for what would"
  },
  {
    "startTime": 522.76,
    "endTime": 524.76,
    "text": "happen to the participants once the"
  },
  {
    "startTime": 524.76,
    "endTime": 525.88,
    "text": "trial has"
  },
  {
    "startTime": 525.88,
    "endTime": 529.88,
    "text": "ended now researchers need to make every"
  },
  {
    "startTime": 529.88,
    "endTime": 532.36,
    "text": "e effort to ensure that an intervention"
  },
  {
    "startTime": 532.36,
    "endTime": 534.6,
    "text": "that has been shown to be beneficial"
  },
  {
    "startTime": 534.6,
    "endTime": 538.8,
    "text": "during a clinical trial is accessible to"
  },
  {
    "startTime": 538.8,
    "endTime": 540.72,
    "text": "the participants of the trial once the"
  },
  {
    "startTime": 540.72,
    "endTime": 543.279,
    "text": "trial has been completed in addition"
  },
  {
    "startTime": 543.279,
    "endTime": 545.48,
    "text": "they should be able to consider the"
  },
  {
    "startTime": 545.48,
    "endTime": 547.72,
    "text": "possibility of introducing and"
  },
  {
    "startTime": 547.72,
    "endTime": 550.16,
    "text": "maintaining effective treatments in The"
  },
  {
    "startTime": 550.16,
    "endTime": 553.64,
    "text": "Wider Community once the trial ends if"
  },
  {
    "startTime": 553.64,
    "endTime": 555.64,
    "text": "for any reason they feel that this might"
  },
  {
    "startTime": 555.64,
    "endTime": 558.0,
    "text": "not be possible then I think they should"
  },
  {
    "startTime": 558.0,
    "endTime": 560.36,
    "text": "have to ethically justify why the"
  },
  {
    "startTime": 560.36,
    "endTime": 562.2,
    "text": "clinical trial should be conducted in"
  },
  {
    "startTime": 562.2,
    "endTime": 565.279,
    "text": "the first place now fortunately for"
  },
  {
    "startTime": 565.279,
    "endTime": 567.92,
    "text": "Seline our meeting did not end in my"
  },
  {
    "startTime": 567.92,
    "endTime": 570.72,
    "text": "office I was able to get her enrolled"
  },
  {
    "startTime": 570.72,
    "endTime": 573.68,
    "text": "into a free HIV treatment program closer"
  },
  {
    "startTime": 573.68,
    "endTime": 576.399,
    "text": "to her home and with a support group to"
  },
  {
    "startTime": 576.399,
    "endTime": 579.76,
    "text": "help her cope her story has a positive"
  },
  {
    "startTime": 579.76,
    "endTime": 582.72,
    "text": "ending but there are thousands of others"
  },
  {
    "startTime": 582.72,
    "endTime": 585.92,
    "text": "in similar situations who are much less"
  },
  {
    "startTime": 585.92,
    "endTime": 589.24,
    "text": "fortunate although she may not know this"
  },
  {
    "startTime": 589.24,
    "endTime": 592.12,
    "text": "my encounter with Seline has completely"
  },
  {
    "startTime": 592.12,
    "endTime": 594.88,
    "text": "changed the way in which I view HIV"
  },
  {
    "startTime": 594.88,
    "endTime": 597.519,
    "text": "clinical trials in developing countries"
  },
  {
    "startTime": 597.519,
    "endTime": 599.88,
    "text": "and made me even more determined to be"
  },
  {
    "startTime": 599.88,
    "endTime": 602.079,
    "text": "part of the movement to change the way"
  },
  {
    "startTime": 602.079,
    "endTime": 604.88,
    "text": "in which things are done I believe that"
  },
  {
    "startTime": 604.88,
    "endTime": 607.519,
    "text": "every single person listening to me"
  },
  {
    "startTime": 607.519,
    "endTime": 610.92,
    "text": "tonight can be part of that change if"
  },
  {
    "startTime": 610.92,
    "endTime": 613.56,
    "text": "you're a researcher I hold you to a"
  },
  {
    "startTime": 613.56,
    "endTime": 616.04,
    "text": "higher standard of moral conscience to"
  },
  {
    "startTime": 616.04,
    "endTime": 618.56,
    "text": "remain ethical in your research and not"
  },
  {
    "startTime": 618.56,
    "endTime": 620.48,
    "text": "compromise human welfare in your search"
  },
  {
    "startTime": 620.48,
    "endTime": 623.16,
    "text": "for answers if you work for a funding"
  },
  {
    "startTime": 623.16,
    "endTime": 625.839,
    "text": "agency or pharmaceutical company I"
  },
  {
    "startTime": 625.839,
    "endTime": 628.88,
    "text": "challenge you to hold your employers to"
  },
  {
    "startTime": 628.88,
    "endTime": 631.8,
    "text": "fund research that is ethically sound if"
  },
  {
    "startTime": 631.8,
    "endTime": 634.04,
    "text": "you come from a developing country like"
  },
  {
    "startTime": 634.04,
    "endTime": 637.0,
    "text": "myself I urge you to hold your"
  },
  {
    "startTime": 637.0,
    "endTime": 639.44,
    "text": "government to a more thorough review of"
  },
  {
    "startTime": 639.44,
    "endTime": 641.76,
    "text": "the clinical trials which are authorized"
  },
  {
    "startTime": 641.76,
    "endTime": 644.72,
    "text": "in your country yes there is a need for"
  },
  {
    "startTime": 644.72,
    "endTime": 647.68,
    "text": "us to find a cure for HIV to find an"
  },
  {
    "startTime": 647.68,
    "endTime": 651.0,
    "text": "effective vaccine for malaria to find a"
  },
  {
    "startTime": 651.0,
    "endTime": 653.959,
    "text": "diagnostic tool that works for TB but I"
  },
  {
    "startTime": 653.959,
    "endTime": 656.24,
    "text": "believe that we owe it to those who"
  },
  {
    "startTime": 656.24,
    "endTime": 659.279,
    "text": "willingly and selflessly consent to prot"
  },
  {
    "startTime": 659.279,
    "endTime": 661.519,
    "text": "participate in these clinical trials to"
  },
  {
    "startTime": 661.519,
    "endTime": 666.88,
    "text": "do this in a humane way thank you"
  }
]